Let’s be real, you already know the facts.

Odds are you’re greater than aware of the three to 4 times greater prevalence of systemic lupus erythematosus (SLE or lupus) amongst Black women in comparison with white women and the varied health disparities within the Black community. With regards to a disease that has such an unpredictable nature, this may be much more frustrating. So, we’re not going to let you know more in regards to the truths you already know too well. As a substitute, we’re going to let you know a couple of possible plan of motion to consult with your doctor. 

Introducing SAPHNELO® (anifrolumab-fnia) injection, for intravenous use: a first-of-its-kind treatment to your one-of-a-kind lupus. SAPHNELO is the primary FDA-approved prescription medicine for adults with moderate to severe SLE who’re receiving other lupus medicines in over a decade. It will not be known if SAPHNELO is effective in patients with severe lively lupus nephritis or central nervous system lupus. It will not be known if SAPHNELO is secure and effective in patients under 18 years of age.

While Black women do share an increased burden from this disease, a universal truth about lupus is that no two cases are the identical. From the best way lupus manifests, to its areas of inflammation, to the impact on quality of life, everyone’s lupus journey is different. Having a lupus treatment option to contemplate to your unique situation is essential to consult with your doctor.

SAPHNELO works across different parts of the body and organs that lupus can affect, in addition to each parts of the immune system. SAPHNELO has been shown to scale back lupus disease activity, which was consistent across different groups of individuals, no matter race or ethnicity. SAPHNELO might also help reduce oral steroid use and lupus flares. Results may vary and all the time consult with your doctor. Please see Necessary Safety Information below.

Oral steroids are sometimes used to regulate lupus disease activity, and a study has shown that chronic steroid use for SLE management is five times more likely in Black patients. It’s important to know that long-term use of steroids can contribute to organ damage and other potential health risks. It is crucial to teach yourself and discuss the advantages and risks for all treatments along with your doctor to find out what’s best for you. 

There isn’t any higher advocate to your health than you. As a Black woman, you’re an element of the most important population affected by lupus. Empower yourself with more knowledge of lupus and advancements in treatment options. Confer with your doctor to seek out out if SAPHNELO is true for you. Within the meantime, visit SAPHNELO.com to learn more.

Take a look at this video to learn more about how SAPHNELO may allow you to be here for more.

Article continues after video.

IMPORTANT SAFETY INFORMATION
•Don’t use SAPHNELO in the event you are allergic to anifrolumab-fnia or to any of the ingredients
•Before you receive SAPHNELO, tell your healthcare provider about your whole medical conditions, including in the event you:
–      think you might have an infection or have an infection that keeps coming back
–      are scheduled to receive a vaccination or in the event you think you could need a
vaccination. You must not receive live vaccines during treatment with
SAPHNELO
–      have or have had cancer
–      are receiving other biologic medicines or monoclonal antibodies
–      are pregnant or plan to change into pregnant. It will not be known if SAPHNELO will harm your unborn baby. Tell your healthcare provider in the event you are, is likely to be, or plan to change into pregnant during treatment with SAPHNELO
          • A pregnancy exposure registry monitors pregnancy outcomes in women exposed to SAPHNELO. Yow will discover out more information in regards to the registry by calling AstraZeneca at 1-877-693-9268
–      are breastfeeding or plan to breastfeed. It will not be known if SAPHNELO passes into your breast milk.

Tell your healthcare provider about all of the medicines you’re taking, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SAPHNELO may affect the best way other medicines work, and other medicines may affect how SAPHNELO works.

SAPHNELO may cause serious unwanted effects, including:
•Serious infections: SAPHNELO can lower the flexibility of your immune system to fight infections. You could be at the next risk of developing respiratory infections and shingles (herpes zoster) during treatment with SAPHNELO. Infections could possibly be serious, resulting in hospitalization or death
•Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can occur during or after you get your SAPHNELO infusion. Tell your healthcare provider or get emergency help instantly if you might have any of the next symptoms of a serious allergic response:
–      swelling of your face, mouth and tongue
–      respiratory problems
–      fainting, dizziness
–      feeling lightheaded (low blood pressure)
•Cancer: SAPHNELO may reduce the activity of your immune system. Medicines that affect the immune system may increase your risk of certain cancers.

Probably the most common unwanted effects of SAPHNELO include:
–      Upper respiratory infections
–      Bronchitis
–      Infusion reactions
–      Shingles (herpes zoster)
–      Cough

Infusion reactions can occur on the time of the infusion or shortly after, symptoms may include headache, nausea, vomiting, feeling drained or weak (fatigue), and dizziness.

These should not all the possible unwanted effects of SAPHNELO. Call your healthcare provider for medical advice about unwanted effects.

APPROVED USE
SAPHNELO is a prescription medicine used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who’re receiving other lupus medicines.

It will not be known if SAPHNELO is effective in patients with severe lively lupus nephritis or severe lively central nervous system lupus. It will not be known if SAPHNELO is secure and effective in patients under 18 years of age.

Please see full Prescribing Information, including Patient Information, for SAPHNELO.

You could report unwanted effects related to AstraZeneca products by clicking here.

SAPHNELO is a registered trademark of the AstraZeneca group of corporations.
©2022 AstraZeneca. All rights reserved. US-62058 Last Updated 7/22